Global Patent Index - EP 0445116 A1

EP 0445116 A1 19910911 - ¬(ARYL-4-PIPERAZINYL-1)-2 ETHOXY -3 P-CYMENE, THE ORTHO, META AND PARA DERIVATIVES MONO- OR DISUBSTITUTED ON THE PHENYL NUCLEUS OF SAID PRODUCT, PROCESS FOR PREPARING SAID DERIVATIVES, AND DRUGS CONTAINING SAID COMPOUNDS AS ACTIVE INGREDIENTS

Title (en)

¬(ARYL-4-PIPERAZINYL-1)-2 ETHOXY -3 P-CYMENE, THE ORTHO, META AND PARA DERIVATIVES MONO- OR DISUBSTITUTED ON THE PHENYL NUCLEUS OF SAID PRODUCT, PROCESS FOR PREPARING SAID DERIVATIVES, AND DRUGS CONTAINING SAID COMPOUNDS AS ACTIVE INGREDIENTS

Title (de)

¬(ARYL-4-PIPERAZINYL-1)-2-ETHOXY -3P-CYMOLE, DIE ORTHO-, META-, PARA-MONOSUBSTITUIERTEN ODER DISUBSTITUIERTEN DERIVATE, DAS VERFAHREN ZU DEREN HERSTELLUNG UND DIE DIESE VERBINDUNGEN ALS AKTIVES PRINZIP ENTHALTENDEN ARZNEIMITTEL

Title (fr)

¬(ARYL-4-PIPERAZINYL-1)-2 ETHOXY -3 P-CYMENE, LES DERIVES ORTHO, META, PARA MONOSUBSTITUES OU DISUBSTITUES SUR LE NOYAU PHENYLE DUDIT PRODUIT, LE PROCEDE DE PREPARATION DESDITS DERIVES, ET LES MEDICAMENTS CONTENANT LESDITS COMPOSES COMME PRINCIPE ACTIF

Publication

EP 0445116 A1 19910911 (FR)

Application

EP 89907194 A 19890613

Priority

FR 8807864 A 19880613

Abstract (en)

[origin: WO8912634A1] The invention concerns the products of general formula (I), in which R1, and R2 are identical or different and are chosen from among a hydrogen atom, a halogen atom, a hydroxyl radical, an alkyl radical containing 1 to 5 C atoms, an alkoxy radical containing 1 to 5 C atoms, a phenoxy, a benzyloxy, a trifluoromethyl and an acetyl radical. It also concerns a process for preparing said products and drugs containing said product.

Abstract (fr)

La présente invention concerne les produits de formule générale (I), dans laquelle R1, R2 sont identiques ou différents, et sont choisis parmi un atome d'hydrogène, un atome d'halogène ou un radical hydroxyle, alkyle ayant de 1 à 5 atomes de carbone, alcoxy ayant de 1 à 5 atomes de carbone, phénoxy, benzyloxy, trifluorométhyle, acétyle. Elle concerne également un procédé de préparation desdits produits et les médicaments contenant lesdits produits.

IPC 1-7

A61K 31/495; C07D 295/08; C07D 295/10

IPC 8 full level

C07D 295/08 (2006.01); A61K 31/495 (2006.01); A61P 13/02 (2006.01); A61P 15/00 (2006.01); C07D 295/092 (2006.01); C07D 295/096 (2006.01); C07D 295/10 (2006.01); C07D 295/112 (2006.01)

CPC (source: EP US)

A61P 13/02 (2017.12 - EP); A61P 15/00 (2017.12 - EP); C07D 295/088 (2013.01 - EP US); C07D 295/096 (2013.01 - EP US); C07D 295/112 (2013.01 - EP US)

Citation (search report)

See references of WO 8912634A1

Designated contracting state (EPC)

AT BE CH DE FR GB IT LI LU NL SE

DOCDB simple family (publication)

EP 0347305 A1 19891220; EP 0347305 B1 19930512; AT E89276 T1 19930515; DE 68906466 D1 19930617; DE 68906466 T2 19930909; DK 168071 B1 19940131; DK 293890 A 19901211; DK 293890 D0 19901211; EP 0445116 A1 19910911; FR 2632641 A1 19891215; FR 2632641 B1 19901012; JP H03505456 A 19911128; US 5110816 A 19920505; WO 8912634 A1 19891228

DOCDB simple family (application)

EP 89401640 A 19890613; AT 89401640 T 19890613; DE 68906466 T 19890613; DK 293890 A 19901211; EP 89907194 A 19890613; FR 8807864 A 19880613; FR 8900298 W 19890613; JP 50700889 A 19890613; US 62371890 A 19901212